Merck (MRK) Current Deferred Tax Assets (2016 - 2023)
Merck (MRK) has disclosed Current Deferred Tax Assets for 15 consecutive years, with $6.6 billion as the latest value for Q2 2023.
- Quarterly Current Deferred Tax Assets fell 2.51% to $6.6 billion in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $6.6 billion through Jun 2023, down 2.51% year-over-year, with the annual reading at $7.2 billion for FY2022, 2.6% up from the prior year.
- Current Deferred Tax Assets for Q2 2023 was $6.6 billion at Merck, down from $6.7 billion in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $7.2 billion in Q3 2022, with the low at $3.2 billion in Q1 2019.
- Average Current Deferred Tax Assets over 5 years is $5.6 billion, with a median of $6.0 billion recorded in 2021.
- The sharpest move saw Current Deferred Tax Assets dropped 21.38% in 2019, then skyrocketed 49.49% in 2021.
- Over 5 years, Current Deferred Tax Assets stood at $4.3 billion in 2019, then grew by 9.28% to $4.7 billion in 2020, then surged by 49.49% to $7.0 billion in 2021, then grew by 2.6% to $7.2 billion in 2022, then decreased by 7.39% to $6.6 billion in 2023.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods came in at $6.6 billion, $6.7 billion, and $7.2 billion for Q2 2023, Q1 2023, and Q4 2022 respectively.